Your Comments On...

U.S. Deal Boosts Radiation Drug

For 16 years, a Columbia biotechnology company has been developing a drug, consisting of adult stem cells derived from healthy bone marrow samples, to treat severe inflammatory diseases that can destroy the body's organs.
 - 

By Zachary A. Goldfarb